You lose fat while gaining muscle simultaneously
In clinical trials of Ozempic and Wegovy, nausea was reported in: 15.8% of people taking a 0.5 milligram (mg) dose 20.3% of people taking a 1 mg dose 44% of people taking a 2.4 mg dose Nausea is a common side effect of semaglutide, but its also seen with other similar medications in the GLP-1 receptor agonist class
Patients should be reassured that gastrointestinal side effects often improve over time as the body adjusts to the medication, particularly if dose escalation is gradual as recommended in the prescribing information
It is about how much weight they can keep off
Ebrahiminejad A, Sepahi AA, Yadegar A, Meyfour A (2024) Pasteurized form of a potential probiotic lactobacillus brevis IBRC-M10790 exerts anti-inflammatory effects on inflammatory bowel disease in vitro
Wegovy Revolutionizing Weight Loss Treatment Among semaglutide products, Wegovy has become particularly influential in transforming obesity care